title: Prospective evaluation of surgical outcomes of robot-assisted sacrocolpopexy and sacrocervicopexy for the management of apical pelvic support defects.
abstract: OBJECTIVE
  To evaluate outcomes of robot-assisted sacrocolpopexy (RSCP) and sacrocervicopexy (RCSP).
  
  
  METHODS
  We conducted a prospective study of women undergoing RSCP or RCSP between June 2008 and January 2010.
  
  
  RESULTS
  A total of 85 cases (48 RSCP and 37 supracervical hysterectomy with concomitant RCSP) were performed: 33% (28/85) for stage II, 54% (46/85) for stage III, and 13% (11/85) for stage IV pelvic organ prolapse (POP). Six weeks postoperatively, 96% (80/83) had stage 0, 2.4% (2/83) had stage I, and 1.2% (1/83) had stage II POP (P < 0.001). Six months postoperatively, 77% (24/31) had stage 0, 6.5% (2/31) had stage I, and 16% (5/31) had stage II POP (P < 0.001). Mean surgical time, estimated blood loss, and length of hospital stay was 194 ± 54 minutes, 49 ± 48 cm, and 1.6 ± 0.72 days, respectively. There were 2 cases of mesh erosion (2.3%), both in the RSCP group.
  
  
  CONCLUSIONS
  RSCP and RCSP are effective, efficient, and safe procedures.
authors.affiliation: Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC 27599-7570, USA. catherine_matthews@med.unc.edu
authors.forename: Catherine A
authors.initials: CA
authors.lastname: Matthews
authors.forename: Ashley
authors.initials: A
authors.lastname: Carroll
authors.forename: Audra
authors.initials: A
authors.lastname: Hill
authors.forename: Viswanathan
authors.initials: V
authors.lastname: Ramakrishnan
authors.forename: Edward J
authors.initials: EJ
authors.lastname: Gill
mesh_terms: D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017773:Pelvic Floor / Q000601:surgery*; D059952:Pelvic Floor Disorders / Q000601:surgery*; D056887:Pelvic Organ Prolapse / Q000601:surgery*; D010388:Pelvis / Q000601:surgery*; D011183:Postoperative Complications; D011446:Prospective Studies; D012371:Robotics / Q000379:methods*; D011795:Surveys and Questionnaires; D016896:Treatment Outcome